NASDAQ: VOR - Vor Biopharma Inc.

Yield per half year: +13.2%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Vor Biopharma Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Vor Biopharma Inc.

Vor Biopharma, Inc. разрабатывает инженерные методы лечения гемопоэтическими стволовыми клетками (EHsc) для онкологических больных. Он предлагает VOR33, продукт-кандидат EHsc, который находится в доклинической разработке для лечения острого миелоидного лейкоза (ОМЛ). В EHSCS VOR33 компании не хватает CD33, белка, который экспрессируется раковыми клетками AML. Vor Biopharma, Inc. была зарегистрирована в 2015 году и базируется в Кембридже, штат Массачусетс.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-02-05
ISIN US9290331084
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.vorbio.com
Цена ао 0.832
Change price per day: -1.81% (0.8473)
Change price per week: -1.42% (0.844)
Change price per month: -36.97% (1.32)
Change price per 3 month: -4.91% (0.875)
Change price per half year: +13.2% (0.735)
Change price per year: -62.35% (2.21)
Change price per 3 year: -86.09% (5.98)
Change price per year to date: -30.08% (1.19)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.12 9
P/E 0 0
EV/EBITDA -1.41 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -56.17 0
ROE, % -78.2 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.291 10
Total: 9

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 1024.37 10
Yield EPS, % 70.3 8
Total: 7.6
More

Institutions Volume Share, %
RA Capital Management, L.P. 22748880 33.37
FMR, LLC 7618948 11.18
Paradigm Biocapital Advisors LP 6457293 9.47
5AM Venture Management, LLC 6361723 9.33
Laurion Capital Management, LP 3182889 4.67
Artal Group S.A. 2347424 3.44
Blackrock Inc. 2251411 3.3
Vanguard Group Inc 1743463 2.56
Woodline Partners LP 1111123 1.63
Johnson & Johnson 1074658 1.58

ETFShare, %Profitability for 1 year, %Dividends, %
Range Cancer Therapeutics ETF 0.69196 47.24 0.11955
iShares Micro-Cap ETF 0.01026 17.09 1.54048
Dimensional U.S. Core Equity 2 ETF 0.00001 30.76 1.47098
0.2331.71.04



Head Job title Payment Year of birth
Dr. Tirtha Chakraborty Ph.D. Chief Scientific Officer 622.96k 1973 (52 years)
Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D. Scientific Founder & Chairman of Scientific Advisory Board N/A 1971 (54 years)
Dr. Eyal C. Attar M.D. Chief Medical Officer N/A 1971 (54 years)

Address: United States, Cambridge, MA , 100 Cambridgepark Drive - open in Google maps, open in Yandex maps
Website: https://www.vorbio.com